Investment in State-of-the-Art Technology
Mammography, ultrasound, or stereotactic breast biopsy - a technologically advanced device being used for the early detection of breast cancer. This technology provides women with an alternative to open surgical breast biopsy. Some of the benefits of this type of biopsy:
- Available as an outpatient procedure, the entire procedure takes 20-30 minutes and women can return to work or normal activities the same day. It requires only a small incision in the skin, about 1/16 of an inch. No stitches are required and scars, if any, are extremely tiny.
- Anesthetic can be delivered into the tissue from the tip of the probe to reduce any discomfort. The probe needs to be inserted only once. It can obtain multiple specimens without having to be repeatedly removed and reinserted.
Frankfort Regional Medical Center is proud to offer the Mammotome Breast Biopsy System, a technologically advanced device being used for the early detection of breast cancer. This technology provides women with an alternative to open surgical breast biopsy.
Breast cancer is the second leading cause of cancer death in women, exceeded only by lung cancer. Biopsy is the only way to tell if an abnormality is cancerous. Biopsies allow for the diagnosis of breast cancer at its earliest, most treatable stage. If detected early, breast cancer can often be treated effectively with surgery that preserves the breast. Five years after diagnosis, more than 90% of women who found breast cancer at its earliest stage are alive and well.
This breast biopsy procedure requires only a local anesthetic to the skin and a single insertion of a special probe to remove the sample tissue. It minimizes the removal of surrounding healthy tissue and virtually eliminates any pain or scarring from the procedure. The biopsy procedure can be performed on an outpatient basis.
Stereotactic breast biopsy has the ability to accurately sample tiny abnormalities in the breast called microcalcifications making early diagnosis of breast cancer easier.